Disease | dystrophic epidermolysis bullosa |
Comorbidity | C0553723|cutaneous squamous cell carcinoma |
Sentences | 2 |
PubMedID- 22564523 | Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. |
PubMedID- 20586780 | Background: tumour-specific expression of matrix metalloproteinase (mmp)-7 has been noted in cutaneous squamous cell carcinomas (sccs) in patients with recessive dystrophic epidermolysis bullosa (rdeb). |
Page: 1